Myelofibrosis successfully treated with prednisolone in a patient with pachydermoperiostosis

14Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Pachydermoperiostosis (PDP) is a rare disorder of bone and connective tissue growth. A 21-year-old man was referred to our hospital with anemia. He showed characteristics of PDP. Bone marrow biopsy showed myelofibrosis. Chromosomal abnormalities or JAK2 mutation were not found. Anemia gradually progressed, and he became transfusion-dependent. Oral prednisolone was initiated; it gradually improved his anemia and rendered the patient free of transfusion. However, other clinical symptoms such as clubbed fingers and skin hypertrophy remained unimproved. In this case, the serum concentration of vascular endothelial growth factor and transforming growth factor-β levels were increased. Further investigation will be necessary to establish appropriate treatment strategies for this disease. © 2011 The Japanese Society of Internal Medicine.

Cite

CITATION STYLE

APA

Ninomiya, S., Hara, T., Tsurumi, H., Kanemura, N., Kasahara, S., Ogawa, Y., … Moriwaki, H. (2011). Myelofibrosis successfully treated with prednisolone in a patient with pachydermoperiostosis. Internal Medicine, 50(19), 2207–2211. https://doi.org/10.2169/internalmedicine.50.5717

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free